In this episode, Josh explores the biblical foundation of evangelism, the power of the Holy Spirit, and practical ways to share the gospel outside the church, including upcoming evangelistic events during the World Cup in Dallas.Chapters00:00 Introduction to Breakthrough Church and Fasting02:50 The Great Commission and Empowerment by the Holy Spirit06:01 The Early Church's Boldness and Miracles09:09 The Call to Evangelism Beyond Church Walls11:51 World Cup Outreach Initiative: Jesus Saves17:06 Invitation to Participate in Evangelism

 In this episode, Josh explores the biblical foundation of evangelism, the power of the Holy Spirit, and practical ways to share the gospel outside the church, including upcoming evangelistic events during the World Cup in Dallas.Chapters00:00 Introduction to Breakthrough Church and Fasting02:50 The Great Commission and Empowerment by the Holy Spirit06:01 The Early Church's Boldness and Miracles09:09 The Call to Evangelism Beyond Church Walls11:51 World Cup Outreach Initiative: Jesus Saves17:06 Invitation to Participate in Evangelism

In this episode of Travel Buddy, Rachel Satow and Jessica Steinberg tackle one of the travel industry's hottest topics: the evolving role of AI in travel marketing. Together, they debate whether artificial intelligence is disrupting traditional strategies or simply bringing new opportunities for engagement, personalization, and efficiency. The conversation explores generational differences, the importance of authentic brand storytelling, and why trust remains central—even in an AI-driven world. Tune in for practical insights and candid perspectives that will help marketers and travel professionals navigate this rapidly changing landscape.Chapters(00:00) Debating AI’s Impact on Travel Marketing(01:00) Traditional Channels vs. AI Integration(05:00) The Importance of Trust and Relationships(06:00) AI Shifting the Marketing Funnel(09:00) Conversational Marketing and Humanized AI(13:00) The Evolving Role of Personalization(14:00) Opportunities, Threats, and Authenticity(18:00) Community, Brand Voice, and Dead Internet Theory(21:00) Practical AI Applications and First-Party Data(26:00) Leveling the Playing Field for Brands(30:00) The Indispensable Role of Human Connection(35:00) Final Reflections on Change, Adaptation, and BalanceResourceshttps://www.phocuswire.com/news/technology/travel-marketing-ai-summit-phocuswright-booking-marriotthttps://vonmackagency.com/community-driven-travel-marketing/https://maddenmedia.com/eight-tourism-marketing-predictions-for-2026/https://travelspike.com/2026-travel-marketing-trends-the-strategic-playbook-for-whats-coming-next/Connect with SwitchflyWebsite: https://www.switchfly.com/LinkedIn: https://www.linkedin.com/company/switchfly/X: https://twitter.com/switchflyYouTube: https://www.youtube.com/@SwitchflyOfficial

In this episode of "In the Interim…", Dr. Scott Berry explores the challenge of protracted endpoint timelines in adaptive clinical trials and the statistical strategies used to increase the rate of actionable information gain. Drawing on detailed case studies from breast cancer (I-SPY 2), Alzheimer’s disease (BAN 2401), diabetes (AWARD-5/Trulicity), and cardiac arrest, Scott addresses the technical demands of longitudinal modeling and interim data imputation for accelerating learning. The discussion prioritizes a critical, empirical perspective of demonstrating how carefully constructed statistical models, simulation, and Bayesian methods can convert interim patient data into more robust estimates of delayed outcomes and support key design adaptations. The episode is a direct account of the methods, uncertainties, and real-world impact of fighting time in adaptive trials.Key HighlightsAnalyzes how delayed primary endpoints challenge adaptive trial efficiency, and how adaptive trial designs use accumulating in-trial data to inform adaptive allocation, arm graduation, and early trial conclusions.Dissects the use of longitudinal models in I-SPY 2, in which interim MRI measurements at one and three months are mapped to predicted six-month pathologic complete response, through an ordinal stratified, pre-specified modeling approach—illustrating both the strengths and limits of interim forecasting.Reviews the BAN 2401 adaptive Alzheimer’s trial, where early cognitive assessments were modeled to forecast 12-month outcomes enabling response adaptive randomization and sample size adaptation based on projections from interim data.Details the AWARD-5 seamless trial for dulaglutide (Trulicity), where strategic enrollment pacing, predictive modeling of early HbA1c and weight loss, and a utility function across four endpoints supported both dose selection and seamless transition to phase 3 without requiring full cohort maturation.Summarizes recent cardiac arrest trial (ICECAP), using 30-day ordinal scales and multiple imputation to predict 90-day outcomes and improve interim decision-making.Unpacks the importance of prior-data-driven modeling, simulation, and strict robustness checks in the construction of all predictive models used for interim adaptation.For more, visit us at https://www.berryconsultants.com/

This week Justin and Mena tackle the hottest market headlines, from SpaceX's eye-popping valuation to the effects of oil prices and inflation on investor portfolios. Backed by real data and hard-won experience, they break down the numbers, challenge the market hype, and share why disciplined decision-making trumps short-term bets for building 100-year family wealth. If you’re ready for candid opinions, memorable lessons from the field, and strategies to protect your legacy, this episode is a must-listen.Chapters(00:00) Forming Opinions Versus Disciplined Action(01:50) SpaceX Valuation and Market Hype(07:29) Short-Term Oil Prices and Geopolitical Impact(13:00) Fed Funds Rate Expectations and Inflation(15:58) Managing Fixed Income and Portfolio RiskConnect with Us• Call or text us: 626-862-0355• Website: https://www.athletefamilyoffice.com/• YouTube: https://www.youtube.com/channel/UCc1NxpK21N1vKWEExC45YEA• LinkedIn: https://www.linkedin.com/company/awmcapital/• Instagram: https://www.instagram.com/awmcapital/• X: https://twitter.com/awmcapital• Facebook: https://www.facebook.com/awmcapital/